1. Home
  2. GVA vs GKOS Comparison

GVA vs GKOS Comparison

Compare GVA & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$123.00

Market Cap

5.2B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$98.96

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVA
GKOS
Founded
1922
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.6B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
GVA
GKOS
Price
$123.00
$98.96
Analyst Decision
Hold
Strong Buy
Analyst Count
3
14
Target Price
$118.33
$133.07
AVG Volume (30 Days)
588.3K
691.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
0.43%
N/A
EPS Growth
47.33
N/A
EPS
3.86
N/A
Revenue
$1,762,965,000.00
$507,442,000.00
Revenue This Year
$13.46
$23.39
Revenue Next Year
$6.83
$27.46
P/E Ratio
$31.30
N/A
Revenue Growth
N/A
32.33
52 Week Low
$69.08
$73.16
52 Week High
$137.24
$130.23

Technical Indicators

Market Signals
Indicator
GVA
GKOS
Relative Strength Index (RSI) 40.30 32.70
Support Level $116.73 $81.54
Resistance Level $124.99 $103.63
Average True Range (ATR) 3.37 3.76
MACD -1.56 -2.15
Stochastic Oscillator 13.12 10.81

Price Performance

Historical Comparison
GVA
GKOS

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: